The Pharmacological Guide to Montelukast


Søren C. Dam (Editor)

Series: Pharmacology – Research, Safety Testing and Regulation
BISAC: MED071000

The Pharmacological Guide to Montelukast opens by presenting the most recent updates on the improvement of montelukast stability and bioavailability, along with some innovative formulations produced by this research. Montelukast is a leukotriene modifier with bronchoprotective and anti-inflammatory actions frequently used in asthma management.

As such, the authors go on to assess the impact of the addition of montelukast to ongoing asthma treatment in terms of improvement in clinical parameters, symptom control and quality of life.

The closing chapter focuses on leukotrienes, formed by leukocytes, which are inflammatory mediators that play an active role in early and late-phase immune response. This group includes montelukast, zafirlukast and prankulast.
(Imprint: Nova Medicine and Health)

Table of Contents

Table of Contents


Chapter 1. Montelukast Encapsulation at the Micro, Nano and Molecular Scale
(Susana Santos Braga, Jéssica Barbosa and Filipe A. Almeida Paz, Chemistry Department, University of Aveiro, Aveiro, Portugal, and others)

Chapter 2. Montelukast as Add-On Therapy to Asthma Treatment Improves Symptom Control and Quality of Life
(Fikret Vehbi Izzettin, PhD, Esra Yildirim, Birsen Pinar Yildiz, MD, PhD, Beyza Torun, Mesut Sancar, PhD, Baris Anil, MD, PhD, Sule Apikoglu-Rabus, PhD, Clinical Pharmacy Department, Bezmialem University Faculty of Pharmacy, Istanbul, Turkey, and others)

Chapter 3. The Efficacy of Montelukast in the Treatment of Allergic Rhinitis
(Cigdem Kalaycik Ertugay, MD, and Ela Araz Server, MD, Department of Otorhinolaryngology/Head and Neck Surgery Istanbul Education and Research Hospital, Istanbul, Turkey)


Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!